Announced
Completed
Financials
Tags
Friendly
Cross Border
genetic testing
Private
Biotechnology
Spain
Single Bidder
Acquisition
Majority
Private Equity
Completed
testing inspection and certification
Synopsis
Vitrolife, a medical technology group, completed the acquisition of Igenomix, a provider of genetic testing services, from EQT Partners, a global investment organization, for $1.48bn. "The combination of Igenomix and Vitrolife brings together two successful organizations that have been committed to innovation and customer service, which will create a global leader in reproductive health focusing on providing the best possible products and services for the IVF clinics to succeed in their strive to support patients becoming parents,” Thomas Axelsson, Vitrolife CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.